The successful application of RNA therapies to rare diseases, neurological disorders, and other conditions as well as the plethora of biopharmaceutical companies developing new RNA-based therapeutics, ...
Scientists have developed a new approach to produce life-saving oligonucleotide therapeutics on a large scale, in high purity, and with minimal environmental impacts. Scientists have developed a new ...
REDWOOD CITY, Calif., Nov. 14, 2024 (GLOBE NEWSWIRE) -- Codexis, Inc. (CDXS), a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, today announced data from ...
Expanded footprint, new capabilities mark IDT’s entrance into CRISPR therapeutics space The 41,000-square-foot-site will produce cGMP cell and gene therapy reagents, including single guide RNAs ...
Driven by Promise of miRNA and siRNA for Therapeutic and Research Applications Even as new players join the competitive market for research- and pharmaceutical-grade oligonucleotides, acquisitions and ...
The MarketWatch News Department was not involved in the creation of this content. DELRAY BEACH, Fla., Jan. 22, 2025 /PRNewswire/ -- The global Oligonucleotide CDMO Market, valued at US$2.33 billion in ...
The "Oligonucleotide Synthesis Market Industry Trends and Global Forecasts to 2035: By Application Area, Type of Product Synthesized, Type of Oligonucleotide Synthesized, Scale of Operation, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results